U.S. stock futures climbed on Monday morning, bouncing back from last week’s losses that were driven by mounting geopolitical tensions. Investors are also turning their attention to this week’s Federal Reserve policy meeting for clues on the direction of interest rates.
Here’s a look at notable premarket stock movers:
- Meta Platforms (NASDAQ:META) edged up 0.7% after the tech giant announced a $14.8 billion investment in Scale AI, a move that includes bringing on the data-labeling startup’s CEO. The deal signals Meta’s deepening commitment to artificial intelligence development.
- Tesla (NASDAQ:TSLA) rose 1.7%, extending Friday’s gains. Investor sentiment improved following reports that U.S. regulators may relax rules that have held back the rollout of fully autonomous vehicles without traditional driver controls.
- Eli Lilly (NYSE:LLY) saw a 0.7% bump after the pharmaceutical firm announced that higher-dose versions of its weight-loss drug Zepbound will now be available directly through its LillyDirect online platform.
- Victoria’s Secret (NYSE:VSCO) shares jumped 3.3% amid reports that activist investor Barington Capital Group is preparing to challenge the company’s current board and push for changes to its shareholder rights plan.
- Sarepta Therapeutics (NASDAQ:SRPT) tumbled 40% in premarket trading following the company’s disclosure of a second fatality linked to its gene therapy for a rare type of muscular dystrophy. The death, caused by acute liver failure, has raised serious safety questions.
- U.S. Steel (NYSE:X) surged 5.1% after former President Donald Trump gave the green light to the company’s partnership with Japan’s Nippon Steel, boosting hopes for cross-border industrial cooperation.
- ReNew Energy Global (NASDAQ:RNW) gained 3.4% after the Indian renewable energy provider reported better-than-expected earnings for the fourth quarter, supported by strong operational performance.
- Celsius Holdings (NASDAQ:CELH) climbed 3.7% following an upgrade from TD Cowen, which shifted its rating from ‘hold’ to ‘buy’. Analysts cited renewed momentum in the company’s growth trajectory, predicting over 30% potential upside.